Skip to main content
. 2021 Jun 10;12:3528. doi: 10.1038/s41467-021-23793-7

Fig. 1. Molecular design and conjugation strategy for generating dual-drug ADCs.

Fig. 1

MTGase-mediated conjugation of bi-functional branched linkers and following orthogonal click reactions with two payload modules afford homogeneous dual-drug ADCs with defined DARs (magenta circle: MMAE; yellow triangle: MMAF). Preparation of anti-HER2 ADC with a DAR of MMAE/F 4 + 2 is shown as an example. The glutamic acid–valine–citrulline (GluValCit)–PABC linker ensures in vivo stability, while allowing for quick and traceless release of payloads upon internalization and following cathepsin-mediated cleavage in lysosomes. DAR, drug-to-antibody ratio; DBCO, dibenzocyclooctyne; MTGase, microbial transglutaminase; PABC, p-aminobenzyloxycarbonyl; PEG, polyethylene glycol; TCO, trans-cyclooctene.